Good care for people with HIV. Rights and Wrongs. Jane Anderson. May 2013

Similar documents
HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

OR: Steps you can take in the clinic to prevent HIV infections

HIV in the United Kingdom: 2009 Report

Using anti-hiv drugs for prevention

HIV testing in England and the NICE Quality Standards

HIV in the United Kingdom

Multiple choice questions: ANSWERS

Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations

PrEP for Women: HIV Prevention in Family Planning Settings

HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech

Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH

2020 Vision: making England s HIV prevention response the best in the world

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect

People who experience gender based violence are more at risk of HIV.

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

Improving outcomes The UK s achievements in managing and preventing the HIV epidemic and how we should approach public health priorities

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention

Why isn t TasP already working?

PrEP: Pre Exposure Prophylaxis

Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK

TasP and PrEP- Wishful thinking in the developing world?

PrEP and Behavioral Strategies for HIV Prevention. Douglas Krakower, MD January 30, 2014

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

Treat All : From Policy to Action - What will it take?

Can women s narratives on emergent HIV biotechnologies gained during medical research reveal future practice and possibilities?

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers

THIRD JOINT CONFERENCE OF BHIVA AND BASHH Dr Zheng Yin. Public Health England. 1-4 April 2014, Arena and Convention Centre Liverpool

NAT submission to inquiry into the use of Immigration Detention

Program to control HIV/AIDS

Pre-Exposure Prophylaxis (PrEP) 1 Prevention of HIV in At-Risk Women:

Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D.

Understanding the Results of VOICE

Can we treat our way out of the HIV epidemic?

Novel HIV Prevention Methods for Women

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017

The Latest on HIV Testing. Dominika Seidman, MD MAS

Drug development in relation to PrEP and the PROUD study

Shebeen Attendees Perceptions of HIV Pre-Exposure Prophylaxis (PrEP) in KwaZulu-Natal Province, South Africa

Linkages between Sexual and Reproductive Health and HIV

Dr Alison Brown. Public Health England. 15 th Annual Conference of the National HIV Nurses Association (NHIVNA)

MTN-020. Jared Baeten, MD PhD Thesla Palanee, PhD On behalf of the ASPIRE team MTN Annual Meeting, Bethesda 21 February 2012

The HIV Prevention Pill: The State of PrEP Science and Implementation. James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE

Dr Laura Byrne. UCL Institute of Child Health, London

Biomedical Prevention in HIV

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

Fertility Desires/Management of Serodiscordant HIV + Couples

Towards universal access

Dr Sonia Raffe. Royal Sussex County Hospital, Brighton. 21 st Annual Conference of the British HIV Association (BHIVA)

HIV Prevention among Women

Government of Canada Federal AIDS Initiative Milestones

HIV PREP THE NEWEST TOOL IN THE BOX

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

Clinical and Public Health Policy Implications of Findings that:

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

Concept paper on the guidance on the non-clinical and clinical development of medicinal products for HIV prevention including oral and topical PrEP

PrEP in the Real World: Clinical Case Studies

PrEP efficacy the evidence

Successful results of clinical trials

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination

What do we need to better understand the needs of mobile and migrant populations in Australia? Is a HIV national response achievable?

HIV/AIDS MODULE. Rationale

HIV in London: A Complexity Challenge

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

South African Guidelines for the Safe Use of. Dr. Oscar Radebe

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

HIV in primary care. How effective and safe are HIV testing and care in General Practice?

Strategic use of antiretroviral drugs to prevent HIV transmission

PRE-EXPOSURE PROPHYLAXIS FOR HIV: EVIDENCE AND GENDER CONSIDERATIONS. Jean R. Anderson M.D. Director, Johns Hopkins HIV Women s Health Program

Sexualised drug use: the national picture. Dr Ellen Heinsbroek HIV & STI Dept, National Infection Service, Public Health England

OUR YOUTH - OUR FUTURE : STREN

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers

GLOBAL AIDS MONITORING REPORT

HIV surveillance in Northern Ireland 2016

ART and Prevention: What do we know?

The Science behind Preexposure Prophylaxis (PrEP) Yunus Moosa Department of Infectious Diseases UKZN

Sexual Health reproduction in reference to treatment as/for prevention

Key issues in a transitional care service

HIV Prevention Strategies HIV Pre-exposure prophylaxis

The HIV Prevention Pill: The State of PrEP Science and Implementation

Biomedical Prevention Update Thomas C. Quinn, M.D.

HIV Prevention in Clinical Care Settings

Male involvement in HIV Prevention Trials

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments

HIV testing as the bridge between awareness and acceptance of PrEP among MSM

Roy M. Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Medical College of Cornell University New York City

Pre-exposure prophylaxis : Systemic and topical. Linda-Gail Bekker The Desmond Tutu HIV Centre UCT SA HIV ClniciansSociety Conference 2012

PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Overview of ARV-based prevention trials

PrEP: Getting to the Tipping Point

Getting Prepped for PrEP. Ken Ho, MD, MPH World AIDS Day

Intimate partner violence (IPV) after disclosure of HIV test results among pregnant women in Harare, Zimbabwe

Transcription:

Good care for people with HIV. Rights and Wrongs Jane Anderson May 2013

Recognition 1981-91 Intervention 1991-2001 Stabilisation 2001-2012 HIV in evolution Crisis management Palliative care Discovery Assessing Efficacy Gaining virological control Effectiveness Chronicity Ageing Prevention Disclosure Modified diagram with thanks to Chu C, J Urban Health. 2011 June; 88(3): 556 566

Slide Courtesy of Dr Danna Rosenfeld, Keele University

Number of people living with diagnosed HIV infection People living with HIV in the UK 80000 70000 Other exposure groups/unknown 60000 People who inject drugs Other heterosexuals 50000 Black African heterosexuals MSM 40000 30000 20000 10000 0 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 HIV and AIDS Reporting System HIV and STI Department, Health Protection Agency - Colindale

Life expectancy (Years) HIV & Life Expectancy in the UK May et al BMJ 2011 Age (years)

Late diagnosis 1 of HIV infection by exposure group: United Kingdom, 2011 HIV and AIDS Reporting System HIV and STI Department, Health Protection Agency - Colindale

Prevalence of diagnosed HIV infection among adults aged 15-59 years by residential deprivation: England, 2011 HIV and AIDS Reporting System HIV and STI Department, Health Protection Agency - Colindale

Delpeche, V. PHE data presented at BHIVA spring meeting 2013

Benchmarking Quality: what is good care?

What should good care deliver? Life that is as fulfilling as possible for as long as possible in the best possible health Maintaining health and wellbeing Sustaining and promoting relationships Staying safe and reducing risk

Angela 44 years old Visits her GP x3 over an 18 month period Night sweats, dry skin, recurrent vaginal candida Develops persistent cough, shortness of breath Admitted to hospital Diagnosed with advanced HIV infection 09/05/2013 11

HIV is under recognised by clinicians Snapshot audit in 2010 1,112 people newly diagnosed with HIV 52.2% baseline CD4 count below 350 c/mm 3 30% clinical symptoms associated with HIV 25% of patients had at least one missed opportunity for an earlier diagnosis Clinical Medicine 2012, Vol 12, No 5: 430 4

Offer and recommend an HIV test Wherever diagnosed HIV is more than 2 / 1000 when registering patients in primary care when admitting patients as general medical admissions to anyone who has a blood test

ALL primary and secondary care Promote testing to people from black African communities Promote testing to men who have sex with men People with indicator conditions Remember repeat testing Offering and recommending a HIV test should be within the existing competencies of health professionals.

Physician barriers to HIV testing HIV testing was offered to 4111 age-eligible patients in Emergency Units or Acute Care Units within the UK Sullivan et al. HINTS Study Group. Available at www.bhiva.org/documents/conferences/timetotest2010/presentations/annsullivan.pdf

Beatrice 26 years old, living with her boyfriend Pregnant. HIV positive test on antenatal screening Tells her partner Relationship deteriorates Her partner becomes abusive. With substantial support Beatrice leaves her partner 09/05/2013 16

Intimate Partner Violence Quantitative, questionnaire based study 350 women with HIV at Homerton Half the women living with HIV studied (n=191) had experienced IPV 1:7 women reported IPV in the previous year 1:7 women reported IPV in pregnancy Dhairyawan R et HIV Medicine 2013

35years old, in a new relationship Tests HIV positive during a routine sexual health screen CD4 count 550 Partner tests HIV negative Colin s clinician discusses treatment to prevent transmission. Colin His partner strongly encourages Colin to start therapy 09/05/2013 18

Treatment as Prevention 1,763 heterosexual HIV-1 serodiscordant couples ART for the infected partner 96% reduction in transmission when HIV-positive partner starts treatment early Cohen M. N Engl J Med. Volume 365(6):493-505 August 11, 2011 BHIVA/EAGA position paper 2013

UK Treatment Guidelines 2012 Treatment to reduce transmission We recommend the evidence that treatment with ART lowers the risk of transmission is discussed with all patients, and an assessment of the current risk of transmission to others is made at the time of this discussion We recommend following discussion, if a patient with a CD4 count above 350 cell/µl wishes to start ART to reduce the risk of transmission to partners, this decision is respected and ART is started GPP GPP www.bhiva.org William,I et al Adult HIV Treatment Guidelines 2012

Biomedical prevention - PrEP 2,499 HIV-negative MSM Daily emtricitabine plus tenofovir versus placebo. Those receiving the antiretroviral medication had a 44% reduction in HIV incidence Detectable blood levels strongly correlated with the prophylactic effect Grant R et al N Engl J Med 363(27):2587-2599 December 30, 2010

How do we use PrEP in the UK? Multi-centre, open label randomised design to immediate or deferred inclusion of pre-exposure prophylaxis as part of the package of HIV risk reduction interventions. 500 HIV negative MSM to be enrolled Results expected 2015

Came to the UK from west Africa to study. Visa now expired. Presents to clinical care with tuberculosis, becomes very sick and needs ITU care. HIV test is positive. Treatment is started and Daniel slowly improves. Daniel Borders Agency alerted and Daniel is subject to immigration detention 09/05/2013 23

Prompt and late HIV diagnosis among non-uk born with associated short-term mortality: UK, 2001-2010 Health Protection Services. Migrant Health: Infectious diseases in non-uk born populations in the United Kingdom. An update to the baseline report 2011. London: Health Protection Agency. 2011 24

HIV in Removal Centres 2009 Access to high-quality clinical primary care services and secondary care with expertise in HIV and associated specialties Appropriate clinical handover to ensure continuity of care Adequate ARVs if removed (3/12) HIV testing (diagnosis for those infected) and prevention (for those uninfected)

Medical Justice London March 2011 http://www.medicaljustice.org.uk/images/ stories/reports/d%26d.pdf

Dual Loyalties: The Challenges of Providing Professional Health Care to Immigration Detainees. Physicians for Human Rights. March 2011 https://s3.amazonaws.com/phr_reports/2011_dualloyalties_final_3_24_2011_opt.pdf

Jonathan Mann 1947-1998 The third epidemic, of social, cultural, economic and political reaction to AIDS...is as central to the global AIDS challenge as the disease itself. Jonathan Mann 1987 Journal of the Royal Statistical Society. Series A (Statistics in Society), Vol. 151, 1. (1988)

09/05/2013 32